NCT06956014ClinicalTrials.gov
Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy
Multicenter, Double-blind, Randomized, Placebo-controlled Phase III Trial to Evaluate the Efficacy and Safety of the Full-spectrum Cannabis Extract VER-01 in Participants With Chronic Painful Lumbosacral Radiculopathy
Kurz gefasst
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not…
Phase 3810 Teilnehmende gesucht43 Studienzentren1 Land
Kategorien
In 1 Register registriert
- ClinicalTrials.govNCT06956014Diesen Eintrag bei ClinicalTrials.gov öffnenSynchronisiert vorgestern
Eine Studie kann in mehreren Registern registriert sein. Wir zeigen sie einmal und verlinken jeden Eintrag, den wir haben.
Die Studieninformationen werden so angezeigt, wie sie vom Register veröffentlicht wurden, in ihrer Originalsprache.
Interesse an dieser Studie?
Anmelden oder ein Konto erstellen um Ihr Interesse zu bekunden und diese Studie zu verfolgen.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Present: Registered before enrolment beganFirst posted 2025-05-02; recorded start 2026-09-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Present: Participants are randomly assignedAllocation is recorded as randomised
- Present: Has a comparison groupThe record lists a placebo or comparator arm, or more than one study arm
- Present: Uses blinding (masking)A masking level is recorded in the record
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Vertanical GmbH)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
- Intervention regulatory context: investigational, within a phased regulatory pathway.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
A strong methodological design for a phase 3 study, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation20/20
Participants are randomly allocated between arms
- Blinding20/20
Quadruple-blind
- Control arm13/15
Placebo / sham control arm
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre0/8
Single site, or site count not stated
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration5/5
Registered before the study start date
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 810 participants (target), run at 43 sites.
How this score is built
- Enrolment29/40
810 participants (target)
- Site count0/25
Site count not stated in the record
- Country count0/15
Country count not stated in the record
- Planned duration7/10
Planned over about 24 months
- Sponsor scale1/10
Vertanical GmbH has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
Zusammenfassung
The aim of the trial is to prove the efficacy and safety of VER-01 compared to placebo in patients with chronic painful lumbosacral radiculopathy (PLSR) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain relief or were unsuitable due to contraindications or intolerance.
Erkrankungen
- Lumbosacral Radiculopathy
Eignung
| Geschlecht | Alle |
|---|---|
| Alter | 18 Years – Kein Höchstalter |
| Gesunde Freiwillige | Nein |
Eignung im Wortlaut des Registers
Eignung in einfachen Aussagen
Die Kriterien dieses Eintrags wurden noch nicht in einzelne Aussagen aufgeschlüsselt. Der Registertext oben ist vollständig und ist die maßgebliche Fassung.
Studiendesign
| Studientyp | Interventionell |
|---|---|
| Phase | Phase 3 |
| Zuteilung | Randomisiert |
| Interventionsmodell | PARALLEL |
| Primäres Ziel | TREATMENT |
| Verblindung | QUADRUPLE (4) |
| Teilnahme | 810 Teilnehmende gesucht |
Sponsor und Mitwirkende
- Vertanical GmbH Sponsor
Studienarme und Interventionen
- VER-01 Dose 1EXPERIMENTAL
- VER-01 Dose 2EXPERIMENTAL
- PlaceboPLACEBO_COMPARATOR
Interventionen
- Sonstige Placebo
Comparator without active ingredient
- Arzneimittel VER-01
Standardized soft extract from Cannabis sativa DKJ127 L., cannabis flos (Cannabis flower), corresponding to 19 mg Δ9-Tetrahydrocannabinol (THC) per ml drug product
Endpunkte
Primärer Endpunkt
Efficacy based on pain reduction
The primary endpoint is the absolute change in mean leg pain intensity in the index leg measured on an 11-point numerical rating scale (NRS) at Treatment Week 12 compared to Baseline.
Zeitrahmen From Baseline to Treatment Week 12
Daten
| Startdatum | 22. September 2026 (tatsächlich) |
|---|---|
| Primärer Abschluss | 1. September 2028 (geschätzt) |
| Abschluss | 1. September 2028 (geschätzt) |
| Erstveröffentlichung | 2. Mai 2025 (tatsächlich) |
| Zuletzt aktualisiert | 19. November 2026 |
| Ergebnisse veröffentlicht | Im Registereintrag nicht angegeben |
| Status zuletzt bestätigt | November 2026 |
Tatsächlich bedeutet, dass das Ereignis eingetreten ist. Geschätzt bedeutet, dass der Sponsor es erwartet. Die beiden bedeuten Unterschiedliches.
Standorte
43 Studienzentren rekrutieren
United States
| Einrichtung | Stadt | Bundesland oder Region | Status |
|---|---|---|---|
| Central Texas Clinical Research, LLC | Austin | Texas | Rekrutiert |
| Boston Clinical Trials | Boston | Massachusetts | Rekrutiert |
| Bradenton Research Center | Bradenton | Florida | Rekrutiert |
| DFW Clinical Trials | Carrollton | Texas | Rekrutiert |
| Epic Medical Research - Carrolton | Carrollton | Texas | Rekrutiert |
| Clinitiative - Clinical Trials of South Carolina - Charleston | Charleston | South Carolina | Rekrutiert |
| Epic Medical Research - Chickasha | Chickasha | Oklahoma | Rekrutiert |
| Velocity Clinical Research - Cleveland | Cleveland | Ohio | Rekrutiert |
| Epic Medical Research - DeSoto | DeSoto | Texas | Rekrutiert |
| Mountain View Clinical Research | Denver | Colorado | Rekrutiert |
| Innovare Research Group I | Friendswood | Texas | Rekrutiert |
| AGA Clinical Trials | Hialeah | Florida | Rekrutiert |
| HD Research - Memorial Hermann Village | Houston | Texas | Rekrutiert |
| Perfizien Clinical Research LLC | Houston | Texas | Rekrutiert |
| Synergy Groups Medical - Southeast Houston | Houston | Texas | Rekrutiert |
| Green Leaf Clinical Trials | Jacksonville | Florida | Rekrutiert |
| R & H Clinical Research | Katy | Texas | Rekrutiert |
| Alliance for Multispecialty Research - Knoxville | Knoxville | Tennessee | Rekrutiert |
| Epic Clinical Research - Lewisville | Lewisville | Texas | Rekrutiert |
| Central Medical Research Institute | Long Beach | California | Rekrutiert |
| Tekton Research - Longmont | Longmont | Colorado | Rekrutiert |
| K2 Medical Research - Maitland II | Maitland | Florida | Rekrutiert |
| Velocity Clinical Research - Medford | Medford | Oregon | Rekrutiert |
| Alma Clinical Research | Miami | Florida | Rekrutiert |
| Floridian Research Institute LLC I | Miami | Florida | Rekrutiert |
| AMR Mobile | Mobile | Alabama | Rekrutiert |
| Monroe Biomedical Research - Monroe | Monroe | North Carolina | Rekrutiert |
| Alliance for Multispecialty Research - Norfolk | Norfolk | Virginia | Rekrutiert |
| Conquest Research - Lake Nona | Orlando | Florida | Rekrutiert |
| Alfa Medical Research - Pembroke Pines | Pembroke Pines | Florida | Rekrutiert |
| Flourish Research - Philadelphia | Plymouth Meeting | Pennsylvania | Rekrutiert |
| United Medical Research | Port Orange | Florida | Rekrutiert |
| Boeson Research | Provo | Utah | Rekrutiert |
| CenExel JBR - Salt Lake City | Salt Lake City | Utah | Rekrutiert |
| Elixia Clinical Research Collaborative | Springfield | Massachusetts | Rekrutiert |
| Professional Health Care of Pinellas | St. Petersburg | Florida | Rekrutiert |
| Velocity Clinical Research - Suffolk | Suffolk | Virginia | Rekrutiert |
| Alliance for Multispecialty Research - Tempe I | Tempe | Arizona | Rekrutiert |
| Alliance for Multispecialty Research - Wichita East | Wichita | Kansas | Rekrutiert |
| Grayline Research Center | Wichita Falls | Texas | Rekrutiert |
| Progressive Medicine of the Triad, LLC | Winston-Salem | North Carolina | Rekrutiert |
| Conquest Research - Winter Park | Winter Park | Florida | Rekrutiert |
| Vitalix Clinical | Worcester | Massachusetts | Rekrutiert |
Studiendokumente
In diesem Registereintrag sind keine Dokumente verlinkt.
Änderungen im Zeitverlauf
- 19. November 2026
Studienzentrum hinzugefügt
11 sites added (43 total)
3243
- 2. November 2026
Studienzentrum hinzugefügt
9 sites added (32 total)
2332
- 21. Oktober 2026
Studienzentrum hinzugefügt
1 site added (23 total)
2223
- 19. Oktober 2026
Studienzentrum hinzugefügt
21 sites added (22 total)
122
- 28. September 2026
Status geändert
Status changed from Not yet recruiting to Recruiting
NOT_YET_RECRUITINGRECRUITING
- 28. September 2026
Studienzentrum hinzugefügt
1 site added (1 total)
01
- 28. September 2026
Rekrutierung eröffnet
Recruitment opened
NOT_YET_RECRUITINGRECRUITING